ALGS
Aligos Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Aligos Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Aligos Therapeutics, Inc.
5.14
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Deep Track CapitalDeep Track Capital | $2.6M | 19.37% | 0.00% | |
| 2 | Alyeska Investment GroupAlyeska Investment | $2.4M | 17.97% | 0.00% | |
| 3 | Sio Capital ManagementSio | $1.9M | 14.27% | 0.00% | |
| 4 | Marshall WaceMarshall Wace | $1.4M | 10.76% | −7.69% | |
| 5 | Woodline PartnersWoodline Partners | $1.0M | 7.74% | 0.00% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $1.0M | 7.66% | −1.53% | |
| 7 | Baker Bros. AdvisorsBaker Bros. | $479,227 | 3.62% | 0.00% | |
| 8 | Hillhouse Capital AdvisorsHillhouse Capital | $439,945 | 3.33% | 0.00% | |
| 9 | D. E. ShawD. E. Shaw | $383,491 | 2.90% | +505.42% | |
| 10 | UBS GroupUBS | $346,119 | 2.62% | +61.86% | |
| 11 | Geode Capital ManagementGeodeindex-like | $272,319 | 2.06% | −5.61% | |
| 12 | Jane Street GroupJane Street | $186,959 | 1.41% | new | |
| 13 | BlackRockBlackRockindex-like | $174,785 | 1.32% | +132.30% | |
| 14 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $165,091 | 1.25% | +0.62% | |
| 15 | Dimensional Fund AdvisorsDimensional | $121,424 | 0.92% | new | |
| 16 | Verition Fund ManagementVerition Fund | $108,978 | 0.82% | 0.00% | |
| 17 | Trexquant InvestmentTrexquant Investment | $71,196 | 0.54% | new | |
| 18 | Renaissance TechnologiesRenaissance Technologies | $62,316 | 0.47% | −89.25% | |
| 19 | Rockefeller Capital ManagementRockefeller | $57,700 | 0.44% | 0.00% | |
| 20 | Federation des caisses Desjardins du QuebecFederation des caisses Desjardins du Quebec | $26,831 | 0.20% | +389.47% | |
| 21 | Golden State Wealth ManagementGolden State Wealth | $15,429 | 0.12% | 0.00% | |
| 22 | Royal Bank of CanadaRoyal Bank of Canada | $12,000 | 0.09% | 0.00% | |
| 23 | CitigroupCitigroup | $10,432 | 0.08% | new | |
| 24 | Tower Research Capital LLC (TRC)Tower Research Capital LLC (TRC) | $2,071 | 0.02% | +452.31% | |
| 25 | JPMorgan ChaseJPMorgan Chase | $1,868 | 0.01% | −48.96% |
31 managers report $13.2M of Aligos Therapeutics on form 13F for the quarter ended Jun 30 '26. 7 of them hold 80% of it; Deep Track Capital is largest at 19.37%.
Linked news
No implied move.
No implied move.
Expected move
No implied move.